Literature DB >> 24048532

Sampling and decontamination method for culture of nontuberculous mycobacteria in respiratory samples of cystic fibrosis patients.

Annelies De Bel1, Deborah De Geyter, Iris De Schutter, Christine Mouton, Isabelle Wellemans, Laurence Hanssens, Petra Schelstraete, Anne Malfroot, Denis Pierard.   

Abstract

We confirmed that chlorhexidine decontamination yielded more nontuberculous mycobacteria than did the N-acetyl-l-cysteine-NaOH-oxalic acid procedure from respiratory samples of cystic fibrosis patients on solid cultures. However, this improved recovery is mostly balanced if the latter is combined with liquid culture. Furthermore, none of the 145 cough swabs, used to sample young children, cultured positive, suggesting that swabs are low-quality samples.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24048532      PMCID： PMC3838033          DOI： 10.1128/JCM.02035-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  11 in total

1.  Comparison of flocked and rayon swabs for collection of respiratory epithelial cells from uninfected volunteers and symptomatic patients.

Authors:  Peter Daley; Santina Castriciano; Max Chernesky; Marek Smieja
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

2.  Value of the chlorhexidine decontamination method for recovery of nontuberculous mycobacteria from sputum samples of patients with cystic fibrosis.

Authors:  Agnès Ferroni; Hoang Vu-Thien; Philippe Lanotte; Muriel Le Bourgeois; Isabelle Sermet-Gaudelus; Brigitte Fauroux; Sophie Marchand; Françoise Varaigne; Patrick Berche; Jean-Louis Gaillard; Catherine Offredo
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

Review 3.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

4.  Comparison of 3 swab transport systems for direct release and recovery of aerobic and anaerobic bacteria.

Authors:  Kenneth G Van Horn; Carol D Audette; Kelly A Tucker; Denise Sebeck
Journal:  Diagn Microbiol Infect Dis       Date:  2008-09-23       Impact factor: 2.803

5.  Cough swabs should not be used to isolate non-tuberculous mycobacteria in children with cystic fibrosis.

Authors:  Bushra Ahmed; Ian M Balfour-Lynn; Khalid Alshafi
Journal:  Arch Dis Child       Date:  2012-07-14       Impact factor: 3.791

6.  Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis.

Authors:  Kenneth N Olivier; David J Weber; Richard J Wallace; Ali R Faiz; Ji-Hyun Lee; Yansheng Zhang; Barbara A Brown-Elliot; Allison Handler; Rebecca W Wilson; Michael S Schechter; Lloyd J Edwards; Subha Chakraborti; Michael R Knowles
Journal:  Am J Respir Crit Care Med       Date:  2002-11-14       Impact factor: 21.405

7.  Nontuberculous mycobacteria in adult patients with cystic fibrosis.

Authors:  J M Kilby; P H Gilligan; J R Yankaskas; W E Highsmith; L J Edwards; M R Knowles
Journal:  Chest       Date:  1992-07       Impact factor: 9.410

8.  Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis.

Authors:  S Whittier; R L Hopfer; M R Knowles; P H Gilligan
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

9.  The role of Mycobacteria Other Than Tuberculosis (MOTT) in patients with cystic fibrosis.

Authors:  K Hjelt; N Højlyng; P Howitz; N Illum; E Munk; N H Valerius; K Fursted; K N Hansen; I Heltberg; C Koch
Journal:  Scand J Infect Dis       Date:  1994

10.  Nontuberculous mycobacterial disease in adult cystic fibrosis patients.

Authors:  M L Aitken; W Burke; G McDonald; C Wallis; B Ramsey; C Nolan
Journal:  Chest       Date:  1993-04       Impact factor: 9.410
View more
  5 in total

Review 1.  Highlight on advances in nontuberculous mycobacterial disease in North America.

Authors:  Mehdi Mirsaeidi; Maham Farshidpour; Mary Beth Allen; Golnaz Ebrahimi; Joseph O Falkinham
Journal:  Biomed Res Int       Date:  2014-09-11       Impact factor: 3.411

2.  Microbiological diagnostic procedures for respiratory cystic fibrosis samples in Spain: towards standard of care practices.

Authors:  Juan de Dios Caballero; Rosa del Campo; Marta Tato; Elia Gómez G de la Pedrosa; Marta Cobo; Carla López-Causapé; Enrique Gómez-Mampaso; Antonio Oliver; Rafael Cantón
Journal:  BMC Microbiol       Date:  2014-12-24       Impact factor: 3.605

3.  Comparison of the RGM medium and the mycobacterial growth indicator tube automated system for isolation of non-tuberculous mycobacteria from sputum samples of cystic fibrosis patients in Belgium.

Authors:  Anaïs Scohy; Sophie Gohy; Vanessa Mathys; Guillaume Sapriel; Laëtitia Toussaint; Florian Bressant; Ali Zitouni; Marie-Noël Teylaert; Marie-Christine Vander Meeren; Alexandre Colmant; Anne Simon; John D Perry; Patrick Lebecque; Emmanuel André
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2018-08-01

4.  Aetiological agents for pulmonary exacerbations in children with cystic fibrosis: An observational study from a tertiary care centre in northern India.

Authors:  Balaji Arvind; Guruprasad R Medigeshi; Arti Kapil; Immaculata Xess; Urvashi Singh; Rakesh Lodha; Sushil Kumar Kabra
Journal:  Indian J Med Res       Date:  2020-01       Impact factor: 2.375

5.  Chlorhexidine decontamination of sputum for culturing Mycobacterium tuberculosis.

Authors:  Shady Asmar; Michel Drancourt
Journal:  BMC Microbiol       Date:  2015-08-05       Impact factor: 3.605
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.